We are building CATALYST, a proprietary platform that ensures biomedical discoveries are on the path to clincial readiness from day 1. Currently focused on solid cancers, CATALYST integrates clnical context directly into the research workflow.
ACCESS CATALYSTFeatured in the SCPS newsletter for embedding clinical context in oncology research.
News FeatureBenchmarking gene signatures across 12,400+ cohorts to ensure clinical translatability.
Platform BuildScaling automated technical due diligence within the Venture Builder Incubator.
VBI Cohort 6Ensuring Research Stays on the Track of Clinical Readiness
Guide biological starting points using our clinical atlas, ensuring the research begins with a patient-relevant foundation.
Structure experiments to reflect real-world patient heterogeneity, ensuring preclinical results are ready for the clinic.
Constant benchmarking of lab results against the clinical atlas to maintain a defensible path to translation.
Making lab discoveries translatable by refining pre-clinical research with clinical context from the earliest stages.
Building clinically translatable assets. Strengthen technical due diligence for Series A/B rounds by proving patient relevance.
Verifying asset value and translatability during acquisition by testing clinical applicability across patient cohorts.
Industrial Skills Semester 2026
Dataset discovery, bulk & single-cell RNA-seq analysis, and clinical meta-analysis pipelines.
RNA-to-Protein mapping, automated clustering with FlowSOM, and rare cell population discovery.
AI cell segmentation, Tumor Microenvironment (TME) analysis, and cell-cell interaction networking.
Metabolomics discovery, LFA device logic design, and analytical validation for FDA/ISO standards.
No coding background required. Students and professionals will build an end-to-end project and publish a reproducible analysis report by the end of each weekend.
Clinical Data Resources & Proprietary Models